Post-earnings recap
Reported
Tue, Aug 7, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's strong EPS performance, beating expectations by a significant margin, led to an 8.65% increase in stock price. Investors reacted positively to the earnings surprise, despite the lack of revenue data. The management's focus on operational efficiency suggests a commitment to improving future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.59 | N/A | +35.81% |
| Revenue | N/A | N/A | N/A |
Management conveyed a positive outlook on earnings performance. However, they did not provide specific revenue guidance or updates.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing efforts to improve operational efficiency.